NCT00932022 - Trospium Chloride XR in Obese Female Patients With Overactive Bladder | Biotech Hunter

Enrollment

127

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

ObesityOveractive BladderIncontinence

Interventions

DRUG

Trospium Chloride, Extended Release (XR)

Trospium chloride extended release 60 mg capsule taken orally once daily for 12 weeks.

OTHER

placebo

Placebo capsule taken orally once daily for either 2 weeks or 14 weeks.

Trial Locations (1)

La Mesa